Lysosomal Storage Diseases, Nervous System  >>  Replagal (agalsidase alfa)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Replagal (agalsidase alfa) / Samaritan Pharma, Takeda
NCT01650779 / 2015-000697-35: A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta

Completed
4
15
US
Agalsidase beta, Fabrazyme®
Genzyme, a Sanofi Company
Fabry Disease
03/13
03/13

Download Options